# Shahram Seyedin-Noor

> Shahram Seyedin-Noor is a seed investor at Civilization Ventures backing Health Care. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Civilization Ventures](https://shizune.co/investors/profile/civilization-ventures)
- Location: San Francisco, United States
- Total investments: 5
- Last investment: Jul 2024
- Lead investor: 40%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/shahramseyedinnoor
- X (Twitter): http://twitter.com/@shahramtweets
- Website: http://www.civilizationventures.com/
- Facebook: http://www.facebook.com/shahram.seyedinnoor

Shahram Seyedin-Noor is a seed investor at Civilization Ventures in San Francisco focused on Health Care and Biotechnology. Shahram Seyedin-Noor is the Founder and General Partner of Civilization Ventures. He attended Pomona College.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 40% |
| Biotechnology | 1 | 20% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 20% |
| Series A | 1 | 20% |
| Series B | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Foresight Diagnostics | Foresight Diagnostics develops novel technology created to detect cancers earlier from a simple blood draw. | $33M | Series B | Jul 30, 2024 |  |
| Foresight Diagnostics | Foresight Diagnostics develops novel technology created to detect cancers earlier from a simple blood draw. | $58.8M | Series B | Apr 27, 2023 |  |
| Wyndly | Wyndly is fixing allergies. We give you lifelong allergy relief with personalized, prescription treatment and phenomenal online care. We’re making an allergy-free life easy and accessible to the 60 million Americans who suffer from environmental allergies. | $2M | Seed | Feb 08, 2023 |  |
| Foresight Diagnostics | Foresight Diagnostics develops novel technology created to detect cancers earlier from a simple blood draw. | $12.5M | Series A | Jun 02, 2021 |  |
| Foresight Diagnostics | Foresight Diagnostics develops novel technology created to detect cancers earlier from a simple blood draw. | $12.5M | Series A | Dec 12, 2020 |  |

5 of 5 investments shown.

## Co-investors
- [Foresite Capital](https://shizune.co/investors/profile/foresite-capital) — VC Fund, 6 deals together
- [Bluebird Ventures](https://shizune.co/investors/profile/bluebird-ventures) — VC Fund, 3 deals together
- [Pear VC](https://shizune.co/investors/profile/pejman-mar-ventures) — VC Fund, 3 deals together
- [Agent Capital](https://shizune.co/investors/profile/agent-capital) — VC Fund, 2 deals together
- [Stanford University](https://shizune.co/investors/profile/stanford-university) — VC Fund, 2 deals together
- [The CU Healthcare Innovation Fund](https://shizune.co/investors/profile/the-cu-healthcare-innovation-fund) — VC Fund, 2 deals together

## About Civilization Ventures

VC Fund · San Francisco, United States

Civilization Ventures invests in visionary founders that are leading the future of health tech and biology-driven innovation. We aim to be the first check and lead investor in highly disruptive companies across digital health, synthetic biology, diagnostics, 3D (bio) printing, and AI/ software-enabled health tech. Our team comprises serialentrepreneurs and industry thought leaders who work tirelessly to help each of our portfolio companies succeed.

2 contacts available at Civilization Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Shahram Seyedin-Noor | Founder and General Partner | https://shizune.co/investors/profile/shahram-seyedin-noor |
| Zoya Khan | Analyst | https://shizune.co/investors/profile/john-irvine |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Shahram Seyedin-Noor invest in?

Shahram Seyedin-Noor invests primarily in Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Shahram Seyedin-Noor last invest?

The most recent investment recorded for Shahram Seyedin-Noor closed in Jul 2024. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co